L-Arginine-hydrochloride-Standard-生命科學(xué)試劑-MCE

Hotline:400-820-3792Inhibitors?ScreeningLibraries?Proteinswww.MedChemEL-Argininehydrochloride(Standard)Cat.No.:HY-N0455ARCASNo.:1119-34-2分?式:C?H??ClN?O?分?量:210.66作?靶點(diǎn):NOSynthase;EndogenousMetabolite作?通路:Immunology/Inflammation;MetabolicEnzyme/Protease儲(chǔ)存?式:PleasestoretheproductundertherecommendedconditionsintheCertificateofAnalysis.BIOLOGICALACTIVITY?物活性L-Arginine(hydrochloride)(Standard)L-Arginine(hydrochloride)的分析標(biāo)準(zhǔn)品。本產(chǎn)品?于研究及分析應(yīng)?。L-精氨酸(L-Arginine)內(nèi)?型?氧化氮合酶(eNOS)產(chǎn)?NO的底物。L-Arginine通過(guò)陽(yáng)離?氨酸轉(zhuǎn)運(yùn)體家族轉(zhuǎn)運(yùn)到?管平滑肌細(xì)胞，在那?它被代謝成?氧化氮(NO)、多胺或L-脯氨酸。L-Arginine有效的?管擴(kuò)張劑，且可被?于誘導(dǎo)實(shí)驗(yàn)性急性胰腺炎[1][2][3][4][5]。REFERENCES[1].BakkerJ,etal.AdministrationofthenitricoxidesynthaseinhibitorNG-methyl-L-argininehydrochloride(546C88)byintravenousinfusionforupto72hourscanpromotetheresolutionofshockinpatientswithseveresepsis:resultsofarandomized,double-blind,placebo-controlledmulticenterstudy(studyno.144-002).CritCareMed.2004Jan;32(1):1-12.[2].TapieroH,etal.I.Arginine.BiomedPharmacother.2002Nov;56(9):439-45.[3].YamadaM,etal.Endothelialnitricoxidesynthase-dependentcerebralbloodflowaugmentationbyL-arginineafterchronicstatintreatment.JCerebBloodFlowMetab.2000Apr;20(4):709-17.[4].MizunumaT,etal.Effectsofinjectingexcessarginineonratpancreas.JNutr.1984Mar;114(3):467-71.[5].SiriviriyakulP,etal.Effectsofcurcuminonoxidativestress,inflammationandapoptosisinL-arginineinducedacutepancreatitisinmice.Heliyon.2019Aug27;5(8):e02222.McePdfHeightCaution:Producthasnotbeenfullyvalidatedformedicalapplications.Forresearchuseonly.Tel:400-820-3792;021-5895